Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 586 AL 600

Increased plasma levels of lipocalin 2 in mild cognitive impairment

Choi J, Lee HW, Suk K.

J Neurol Sci. 2011 Jun 15;305(1-2):28-33. doi: 10.1016/j.jns.2011.03.023. Epub 2011 Apr 3.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. doi: 10.1248/yakushi.131.505.

Diagnostic dilemma in an elderly woman

Khan F, Curtice M.

BMJ. 2011 Apr 6;342:d969. doi: 10.1136/bmj.d969.

Alzheimer's disease: the challenge of the second century

Holtzman DM, Morris JC, Goate AM.

Sci Transl Med. 2011 Apr 6;3(77):77sr1. doi: 10.1126/scitranslmed.3002369.

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group.

Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8.

Amyloid-dependent and amyloid-independent stages of Alzheimer disease

Hyman BT.

Arch Neurol. 2011 Aug;68(8):1062-4. doi: 10.1001/archneurol.2011.70. Epub 2011 Apr 11.

Posterior cortical atrophy: a rare visual variant of Alzheimer's disease

Gafoor VA, Jose J, Saifudheen K, Musthafa M.

Neurol India. 2011 Mar-Apr;59(2):297-9. doi: 10.4103/0028-3886.79154.

The involvement of multiple caregivers in cognitive-behavior therapy for anxiety in persons with dementia

Robinson CM, Paukert A, Kraus-Schuman CA, Snow AL, Kunik ME, Wilson NL, Teri L, Stanley MA.

Aging Ment Health. 2011 Apr;15(3):291-8. doi: 10.1080/13607860903493374.

Reversible limbic encephalitis in a person with Alzheimer's disease

Klimkowicz-Mrowiec A, Furgal M, Slowik A, Szczudlik A.

J Am Geriatr Soc. 2011 Apr;59(4):757-9. doi: 10.1111/j.1532-5415.2011.03340.x.

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

Delusion of reduplication of tongue accompanied by dangerous self-treatments in a patient with Alzheimer's disease

Hayashi H, Suzuki A, Matsumoto Y, Otani K.

Aust N Z J Psychiatry. 2011 May;45(5):427. doi: 10.3109/00048674.2011.566548.

Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.

Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients

Hattori H, Hattori C, Hokao C, Mizushima K, Mase T.

Geriatr Gerontol Int. 2011 Oct;11(4):431-7. doi: 10.1111/j.1447-0594.2011.00698.x. Epub 2011 Apr 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias